A podcast series highlighting fascinating stories of medical research ThinkResearch Podcast
At a glance
Useful for
  • All audiences: Faculty, researchers, students, and the general public who might be interested in hearing fascinating stories of research

We all are impacted by, and reap the benefits of, medical research discoveries. From over-the-counter drugs, to healthcare policies and educational interventions, many of these advancements are a result of incredible feats, decades of work, and sometimes serendipitous events. Join us as we sit down with Harvard researchers to discuss these captivating behind-the-scenes stories of research.

August 8, 2018: Advancing Imaging



Oren Ganor

Raj Gupta is an associate radiologist in the Neuro and Emergency Radiology Divisions at Massachusetts General Hospital (MGH), an associate professor of radiology at Harvard Medical School, and a lecturer in mechanical engineering at MIT. Gupta earned his MD at Cornell University, PhD in computer science at the State University of New York at Stony Brook, and his MSc in physics and BE in electrical engineering from BITS, Pilani. He serves as CIMIT Site Miner and director of the Advanced X-ray Imaging Sciences (AXIS) Center at MGH. Prior to joining MGH, Gupta was a computer scientist at GE Global Research Center in Niskayuna, New York, where he conducted research in medical imaging, non-destructive evaluation of aircraft engine parts, and computer vision. Gupta's research interests include development and clinical applications of novel X-ray imaging modalities, development of low-cost, lightweight robots for image-guided interventions, and study of traumatic brain injury (TBI) using advanced, quantitative MRI techniques.


July 25, 2018: Quality Care for Transgender Communities



Oren Ganor

Oren Ganor, MD, is a plastic and reconstructive surgeon at Boston Children’s Hospital (BCH) and founder and co-director of the hospital’s Center for Gender Surgery. He trained in medicine at the Hebrew University of Jerusalem and completed a Harvard fellowship in breast reconstruction and microsurgery at Beth Israel Deaconess Medical Center. He also completed a fellowship in craniofacial and pediatric plastic surgery at BCH. He has presented widely on gender-affirming surgery and transgender health.




July 11, 2018: Green Means Go: Healthy Choice Intervention

Read more for details.


Anne Thorndike, MD, MPH, is an assistant professor of medicine at Harvard Medical School and an associate physician at Massachusetts General Hospital (MGH) in Boston. Thorndike is the director of the Metabolic Syndrome Clinic at the MGH Cardiovascular Disease Prevention Center. Her clinical and research interests are the prevention and treatment of obesity and cardiometabolic disease through lifestyle modification. Her research focuses on interventions utilizing behavioral economics strategies, including traffic-light labels and choice architecture, to improve dietary intake and health outcomes in worksite and community-based settings. She is particularly interested in improving healthy food choices among low-income populations, especially those participating in government food assistance programs.


June 20, 2018: Working through the Noise of Big Brain Data

Read more for details.


Caterina Stamoulis, PhD, completed her studies (BS, MS, PhD) at MIT, receiving her PhD in the field of underwater acoustics. For several years, she conducted research broadly in remote sensing and underwater acoustics. In 2004, Stamoulis switched research fields to computational neuroscience. Following post-doctoral training in neuroscience (MIT) and biostatistics (Harvard T.H. Chan School of Public Health), she joined the faculty at Harvard Medical School in 2009, where she is currently an assistant professor of pediatrics.

Stamoulis' broad research interests are in computational neuroscience, neural signal processing, neurostatistics, and bioinformatics. Her current studies focus on the development of novel methodologies for the detection and characterization of normal and abnormal dynamic events in very high-dimensional brain data, and the characterization of the functional neural circuitry that supports sensory processing in the developing human brain. Her research is supported by the National Science Foundation's Brain Initiative as well as the National Institutes of Health.


June 6, 2018: Understanding Wellness with Patient-Centered Research

Read more for details.


Roscoe Brady, PhD, began his training in the MSTP (combined MD-PhD) program at Columbia University. He has a background in neurobiology, having completed his PhD thesis in the laboratory of Nobel laureate Richard Axel MD. Brady subsequently completed his psychiatry training at the Massachusetts General Hospital-McLean Hospital adult psychiatry residency program. His research focus has been elucidating the brain circuit pathophysiology of bipolar disorder. Through the use of magnetic resonance imaging in human subjects with bipolar disorder, his team has published several studies demonstrating how bipolar mood states are represented in changes at the circuit level. This research has been funded by an NIMH K23 Award. He is currently funded by an NIH (K23 award) grant.


May 23, 2018: Phasing into the Future of Children's Epilepsy

Read more for details.


Christos Papadelis, PhD, is an assistant professor of pediatrics at Harvard Medical School and head of the Children's Brain Dynamics laboratory in the Division of Newborn Medicine at Boston Children's Hospital. Papadelis has more than ten years of experience in magnetoencephalography (MEG) and electroencephalography (EEG) technology with both adults and children. He received his diploma in electrical engineering from the Aristotle University of Thessaloniki, Greece, in 1998, as well as his MSc and PhD in Medical Informatics in 2001 and 2005, respectively. His research covers a broad range of studies on neuroscience, clinical neurophysiology, and biomedical engineering. Papadelis has a demonstrated record of productive research projects leading to more than 40 peer-reviewed research investigation articles and numerous articles in conference proceedings. He has projects funded by the National Institute of Child Health and Human Development, the American Epilepsy Society, the Faculty Development Office at Harvard Medical School, and Boston Children's Hospital.


May 9, 2018: In the Zone or Choking under Pressure

Read more for details.


Roland A. Carlstedt, PhD, is a licensed clinical psychologist, board-certified sport psychologist, and chairman and chief sport psychologist of the American Board of Sport Psychology. He holds research appointments in the departments of psychiatry at Harvard Medical School and McLean Hospital. Carlstedt's research has been published in Biofeedback, Cortex, Brain and Cognition, and the Journal of the American Board of Sport Psychology. He has consulted with numerous elite athletes, teams, and organizations worldwide, including the Harlequins Professional Rugby Union Team (London) and the Polish Tennis Federation, as well as trained numerous international practitioners including India's Olympic-medal winning marksmanship team's sport psychologist.


April 18, 2018: Protein Engineering: Editing Functionality

Read more for details.

Michael Super, PhD, is a senior staff scientist with the Advanced Technology Team at the Wyss Institute for Biologically Inspired Engineering at Harvard University and the scientific founder of Opsonix, Inc. Super is a mentor in the Summer Clinical & Translational Research Program at the Harvard Catalyst Program for Faculty Development & Diversity Inclusion. Super's research leverages protein engineering to design therapeutics and diagnostic devices to treat cancer and infectious and immunological diseases. Prior to joining the Wyss Institute, Super spent 17 years in the biotechnology industry, where he focused on the design, development, and production of therapeutic antibodies for cancer and autoimmune diseases.


April 4, 2018: The Science of Adding and Subtracting: Modeling Outcomes of Disease

Read more for details.


Nick Menzies, PhD, is an assistant professor of global health in the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health, and faculty of the Harvard Center for Health Decision Science. Professor Menzies uses decision science and quantitative research to understand the consequences of major policy change, and to design effective disease control programs where resources are limited. His research combines empirical data with mathematical modeling to examine infectious disease control policy in high burden settings. Currently, his focus is on the intersection of HIV and TB epidemics in sub-Saharan Africa and other high-burden settings.


March 21, 2018: Sciences, Ethics, and the World of Objectivity

Read more for details.


Jonathan Beckwith, PhD, was appointed to the faculty of the Department of Bacteriology and Immunobiology at Harvard Medical School in 1965 and to tenure in that department in 1969. Beckwith directed a research group at HMS from 1965 until he closed his laboratory in 2017. During his tenure, 38 students received their PhD and approximately 65 individuals did postdoctoral research in his laboratory. Despite Beckwith's training in chemistry, he considers himself to be a bacterial geneticist. Conducting studies mainly in the bacterium E. coli, Beckwith used genetic approaches to understand regulation and the mechanisms whereby bacterial cells export proteins through their cellular membranes. In late 1980s, he made an unexpected discovery that the formation of covalent disulfide bonds between pairs of cysteines in bacterial proteins is dependent on a cellular set of enzymes and molecules required for this process. These studies led him to direct his efforts toward the development of antibiotics against bacterial pathogens that would interfere with the process of disulfide bond formation.


March 7, 2018: Outcomes and Implications: Understanding Genetic Engineering

Read more for details.


Jonathan Beckwith, PhD, was appointed to the faculty of the Department of Bacteriology and Immunobiology at Harvard Medical School in 1965 and to tenure in that department in 1969. Beckwith directed a research group at HMS from 1965 until he closed his laboratory in 2017. During his tenure, 38 students received their PhD and approximately 65 individuals did postdoctoral research in his laboratory. Despite Beckwith's training in chemistry, he considers himself to be a bacterial geneticist. Conducting studies mainly in the bacterium E. coli, Beckwith used genetic approaches to understand regulation and the mechanisms whereby bacterial cells export proteins through their cellular membranes. In late 1980s, he made an unexpected discovery that the formation of covalent disulfide bonds between pairs of cysteines in bacterial proteins is dependent on a cellular set of enzymes and molecules required for this process. These studies led him to direct his efforts toward the development of antibiotics against bacterial pathogens that would interfere with the process of disulfide bond formation.


February 21, 2018: Inspired Science: Studying Genetics during Times of Resistance

Read more for details.


Jonathan Beckwith, PhD, was appointed to the faculty of the Department of Bacteriology and Immunobiology at Harvard Medical School in 1965 and to tenure in that department in 1969. Beckwith directed a research group at HMS from 1965 until he closed his laboratory in 2017. During his tenure, 38 students received their PhD and approximately 65 individuals did postdoctoral research in his laboratory. Despite Beckwith's training in chemistry, he considers himself to be a bacterial geneticist. Conducting studies mainly in the bacterium E. coli, Beckwith used genetic approaches to understand regulation and the mechanisms whereby bacterial cells export proteins through their cellular membranes. In late 1980s, he made an unexpected discovery that the formation of covalent disulfide bonds between pairs of cysteines in bacterial proteins is dependent on a cellular set of enzymes and molecules required for this process. These studies led him to direct his efforts toward the development of antibiotics against bacterial pathogens that would interfere with the process of disulfide bond formation.


February 7, 2018: Metabolic Pathways and Tumor Treatment

Read more for details.


Carmen Priolo, MD, PhD, is an assistant professor of medicine at Harvard Medical School, a faculty member of the Division of Pulmonary and Critical Care Medicine at Brigham and Women's Hospital, and an associate member of the Broad Institute of MIT and Harvard. She completed her medical degree and specialty training in medical oncology at the University of Messina and the Regina Elena Cancer Institute in Rome, Italy, and her doctoral and post-doctoral research training at the Dana-Farber Cancer Institute. Priolo's research interests include patient-derived pre-clinical models of cancer and the links between genetics and metabolism in cancer. The Priolo lab studies cellular metabolic abnormalities that can be targeted therapeutically and used to improve diagnostics in Tuberous Sclerosis Complex (TSC)-associated tumors and mTOR-driven cancers.


January 24, 2018: For Human Use: Bringing Together a Community to Fight Angiosarcoma

Read more for details.


Corrie Painter, PhD, is the associate director of operations and scientific outreach at the Broad Institute. A trained cancer researcher with a PhD in biochemistry, Painter partners with advocacy groups and engages patients with metastatic breast cancer through social media in order to carry out the Metastatic Breast Cancer Project, a genomics study conducted at the Broad Institute where patients can consent online to donate their stored tumor samples, saliva, medical records, and their voice in order to directly accelerate the pace of discovery.


January 10, 2018: Let's Get Clinical: The Role of Physical Activity in Preventing Disease

Read more for details.


I-Min Lee, MD, ScD, FACSM, is a professor of medicine at Harvard Medical School and professor of epidemiology at the Harvard T.H. Chan School of Public Health. Her primary area of interest is in the role of physical activity for preventing chronic diseases and enhancing longevity. Lee has served on national and international expert panels developing physical activity guidelines, including the 2008 US Physical Activity Guidelines, the 2010 WHO Global Recommendations on Physical Activity for Health, and the 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk.


December 20, 2017: Cows to Coumadin

Read more for details.


Elliott Antman, MD, is professor of medicine and an associate dean for Clinical/Translational Research at Harvard Medical School (HMS), a senior investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group, and a senior physician in the Cardiovascular Division of Brigham and Women's Hospital (BWH). He was president of the American Heart Association (2014-2015) and is now the immediate past president. The American Heart Association honored him with the 2016 Paul Dudley White Award.


December 6, 2017: Big Data and Precision Medicine: Improving Studies and Results

Read more for details.


Elliott Antman, MD, is professor of medicine and an associate dean for Clinical/Translational Research at Harvard Medical School (HMS), a senior investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group, and a senior physician in the Cardiovascular Division of Brigham and Women's Hospital (BWH). He was president of the American Heart Association (2014-2015) and is now the immediate past president. The American Heart Association honored him with the 2016 Paul Dudley White Award.


Brian Healy, PhD, is an assistant professor of neurology at HMS, the primary biostatistician for the Partners MS Center at BWH, and a member of the Massachusetts General Hospital (MGH) Biostatistics Center. He is the director of the Harvard Catalyst Certificate in Applied Biostatistics, which is a 35-week, primarily online course that introduces medical researchers to most commonly used techniques in the medical literature. He was the instructor for Principles of Biostatistics II (BIO203) at the Harvard Chan School for four years, and this past summer he taught the introductory biostatistics module for the Master's Program in Clinical and Translational Investigation at HMS. In addition to full courses, Healy has led several short courses related to biostatistics at MGH. He has given lectures related to biostatistics for several courses including the Introduction to Clinical Investigation (ICI) and Fundamentals of Clinical and Translational Research (FaCToR) through Harvard Catalyst, and the Design and Conduct of Clinical Trials at MGH. He also has taught online and on-site courses as part of the HMS-Portugal Program and the Global Clinical Scholars Research Training Program. Healy's research focuses on modeling the disease course in patients with multiple sclerosis.


November 22, 2017: Using Chemistry to Predict

Read more for details.


Alexander P. Lin, PhD, is the director of the Center for Clinical Spectroscopy in the department of radiology at Brigham and Women's Hospital (BWH) and assistant professor of radiology at Harvard Medical School (HMS). Lin is a graduate of the California Institute of Technology, where he completed his master's degree in bioengineering and his doctoral degree in biochemistry and molecular biophysics. Lin commenced at BWH in 2009, where his research has focused on translating magnetic resonance spectroscopy to the clinic, including a strong research focus on traumatic brain injury. He was awarded the ESMRB Young Investigator's Award in 2003 for his work in 13C spectroscopy in Alzheimer's disease and more recently, the Young Mentor Award at HMS. Lin is also an investigator at the Psychiatric Neuroimaging Laboratory at BWH, visiting research associate at the Center of MR Research at the University of Illinois Chicago, and is affiliated with Massachusetts General Hospital and Boston Children's Hospital.


November 8, 2017: From Bench to Bedside: The Research of Plastic Surgery

Read more for details.


Giorgio Giatsidis, PhD, is an investigator in the Division of Plastic Surgery, Department of Surgery at Brigham and Women's Hospital, and an instructor in surgery at Harvard Medical School. He graduated in medicine at the San Raffaele University of Milan and specialized in plastic surgery at the University of Padova where he pursued his PhD in regenerative medicine. Giatsidis is an innovator in the field of reconstructive surgery, tissue engineering, and regenerative medicine. His research focuses on the development of translational approaches for soft tissue reconstruction, wound healing, and skeletal muscle regeneration. In particular, Giatsidis's research endeavors aim to harness the biological effects of mechanical forces, bio-inductive scaffolds, and adipose-derived stem cells to establish innovative treatments for patients in need of reconstructive procedures after trauma, cancer, chronic diseases, or congenital malformations. His studies have been presented at more than 40 national and international meetings.

Additional Resources


October 18, 2017: Reducing the Effects: The Study of Strokes

Read more for details.


W. Taylor Kimberly, MD, PhD, is a critical care and stroke neurologist in the Department of Neurology at Massachusetts General Hospital. He is the Associate Chief of the Division of Neurocritical Care and Emergency Neurology, and Associate Director of the MGH Neuroscience Intensive Care Unit. Kimberly's clinical interests focus on the critical care management of acute neurological and neurosurgical diseases, and the Kimberly lab studies mechanisms of secondary injury after acute stroke and subarachnoid hemorrhage. His laboratory also develops and implements novel biomarker tools to characterize the types of secondary brain injury, linking them to molecular pathways. These studies are also connected to Kimberly's leadership in the conduct of multicenter phase 2 and phase 3 clinical trials, including the GAMES-Pilot, GAMES-RP, and CHARM trials.


October 4, 2017: Fighting Cancer using the Immune System

Read more for details.


Niroshana Anandasabapathy, MD, PhD, is an investigative physician scientist formally trained in clinical translation, cancer biology, immunology, and dermatology. She is an Assistant Professor of Dermatology at Brigham and Women's Hospital and the Dana-Farber Cancer Institute (DFCI), specializing in melanoma. Anandasabapathy conducts laboratory-based investigation in the fields of cutaneous immunology and cancer immunotherapy, studying tissue specific mechanisms of tumor immune escape. Her research program broadly investigates how mechanisms of tissue homeostasis in peripheral tissues such as skin lead to tumor immune escape of skin cancers. She is a member of the BWH Department of Dermatology post-doctoral scholarship oversight committee, the Harvard Stem Cell Institute, and Harvard Program in Immunology.


September 20, 2017: A National Debate: The Affordable Care Act

Read more for details.


Benjamin Sommers, MD, PhD, is associate professor of health policy and economics at the Harvard T.H. Chan School of Public Health, and associate professor of medicine at Harvard Medical School. He is a health economist and primary care physician whose main research interests are health policy for vulnerable populations and the health care safety net. Sommers has received numerous awards for his research, including the 2017 Health Services Research Impact Award for his work on the Affordable Care Act, the 2015 Article-of-the-Year Award from AcademyHealth, and the Outstanding Junior Investigator Award from the Society of General Internal Medicine. In 2011-2012, he served as a senior adviser in the Office of the Assistant Secretary for Planning and Evaluation in the U.S. Department of Health and Human Services. His research has been published in journals such as the New England Journal of Medicine, Journal of the American Medical Association, Journal of Health Economics, and Health Affairs, and covered by the New York Times, Wall Street Journal, Washington Post, and National Public Radio. His current research projects focus on barriers to health care access among low-income adults, Medicaid policy, and national health reform.

Additional Resources


September 6, 2017: The Chemical Effect: Looking at Health Disparities in Exposure

Read more for details.


Tamarra James-Todd, MPH, PhD, is the Mark and Catherine Winkler Assistant Professor of Environmental Reproductive and Perinatal Epidemiology in the Departments of Environmental Health and Epidemiology at the Harvard T.H. Chan School of Public Health.  As an epidemiologist, her research focuses on environmental chemical exposures, reproductive health outcomes, and racial/ethnic disparities in women's health.  She was among the first to report that phthalates, synthetic chemicals used as plasticizers in many consumer products, were associated with diabetes and diabetes risk markers in women.  James-Todd's work currently focuses on environmental chemicals and metabolic dysregulation in pregnancy. 


August 23, 2017: A Global Health Concern: Providing Surgical Care for All

Read more for details.

Mark G. Shrime, MD, MPH, PhD, FACS, is an assistant professor of Otolaryngology and of Global Health and Social Medicine at Harvard Medical School, and serves as the research director at the Program in Global Surgery and Social Change at Harvard Medical School. In addition, he is an otolaryngologist at the Massachusetts Eye and Ear Infirmary, and associate faculty at Ariadne Labs. His academic pursuits focus on surgical delivery in low- and middle-income countries, where he has a specific interest in the intersection of health and impoverishment. His work aims to determine optimal policies and platforms for surgical delivery that maximize health benefits while simultaneously minimizing the risk of financial catastrophe faced by patients. Shrime received his MD from the University of Texas in 2001, after taking a year to teach organic chemistry in Singapore. Medical school was followed by a residency in otolaryngology at the joint Columbia/Cornell program in Manhattan, followed, in turn, by a fellowship in head and neck surgical oncology at the University of Toronto in 2007. He completed a second fellowship in microvascular reconstructive surgery, also at the University of Toronto, in 2008. Shrime was the first to identify a novel independent prognostic indicator in head and neck cancer. To date, he has worked and taught in Liberia, Sierra Leone, Guinea, Benin, Togo, Congo, Haiti, Saudi Arabia, and Madagascar. In May, 2011, he graduated with an MPH in global health from the Harvard T.H. Chan School of Public Health, where he was a finalist for both the Albert Schweitzer award and the Harvard T.H. Chan School of Public Health Student Recognition award. In May, 2015, he received his PhD in health policy from Harvard University, with a concentration in decision science. His research is supported by the Damon Runyon Cancer Foundation, the GE Foundation's Safe Surgery 2020 project, and the Steven C. and Carmella Kletjian Foundation. When not working, he is an avid photographer and rock climber, and has competed on Seasons 8 and 9 of American Ninja Warrior.


August 9, 2017: Predicting the Path: The Study of Infectious Diseases

Read more for details.


Bill Hanage, PhD, is associate professor of epidemiology at the Harvard University T.H. Chan School of Public Health and a faculty member in the Center for Communicable Disease Dynamics. He researches the epidemiology and evolution of infectious diseases, using genetics to trace the emergence and spread of dangerous pathogens causing pneumonia, meningitis, and drug resistant infections. Hanage also uses computer models to investigate their evolution, with a focus on the remarkable ability of bacterial genes to 'jump' from one species to another. He has written over 100 articles and book chapters on these subjects and has won the Fleming Prize for his research, named for the discoverer of penicillin, Alexander Fleming.


July 26, 2017: The S.M.A.R.T. Bandage: Improving Measurement of Tissue Health

Read more for details.


Conor L. Evans, PhD, received his degree from Harvard University. He carried out his postdoctoral training research in the application of advanced microscopy to cancer research, and now serves as an assistant professor at the Wellman Center for Photomedicine of Harvard Medical School at the Massachusetts General Hospital. His lab's research is focused on the development and clinical translation of optical microscopy and spectroscopy tools, with specific interests in ultrasensitive detection of molecular markers, label-free imaging of tissues, and the imaging and quantification of tissue oxygenation. Evans has led the use of coherent Raman imaging technologies in biomedicine, and was the first to apply this imaging toolkit for the real-time visualization of lipids in skin in vivo. He has spearheaded the development of a number of imaging devices and methods, including coherent Raman imaging, nanoparticle imaging toolkits, and "smart" sensing bandages. He currently holds 11 patents and patent applications and has more than 45 peer-reviewed publications. A recipient of the NIH Director's New Innovator Award, his recent efforts in the synthesis of bright oxygen sensors has resulted in the creation of four new porphyrin molecules that are currently being translated for clinical use.

Haley L. Marks, PhD, is a current postdoctoral research fellow at Massachusetts General Hospital's Wellman Center for Photomedicine. Under the direction of Conor L. Evans, PhD, her current work focuses on the development of phosphor-embedded adhesive materials which allow for imaging and quantification of transcutaneous tissue oxygenation. She received her PhD in biomedical engineering in the Optical BioSensing Lab at Texas A&M University under Gerard Coté, PhD, in 2016. Marks received a 2014 Whitaker International Fellowship to conduct research involving aptamer-functionalized plasmonic magnetic nanoparticles in the lab of Duncan Graham, PhD, at the University of Strathclyde in Glasgow Scotland, and was a recipient of a 2016 Ocean Optics Young Investigator award for this work. Her current research interests include translational biophotonics, nanotechnology, point-of-care monitoring, and bioanalytical sensors.


July 12, 2017: Studying Abroad: Researching the Spread of Disease

Read more for details.


Caroline Buckee, PhD, joined Harvard School of Public Health in 2010 as an assistant professor of epidemiology, and in 2013, was named the associate director of the Center for Communicable Disease Dynamics. Her focus is on elucidating the mechanisms driving the dynamics and evolution of the malaria parasite and other genetically diverse pathogens. After receiving a PhD from the University of Oxford, Buckee worked at the Kenya Medical Research Institute to analyze clinical and epidemiological aspects of malaria as a Sir Henry Wellcome Postdoctoral Fellow. Her work led to an Omidyar Fellowship at the Santa Fe Institute, where she developed theoretical approaches to understanding malaria parasite evolution and ecology. Her work at Harvard extends these approaches using mathematical models to bridge the biological scales underlying malaria epidemiology. Buckee works with experimental researchers to understand the molecular mechanisms within the host that underlie disease and infection, and uses genomic and mobile phone data to link these individual-level processes to understand population level patterns of transmission. She was named one of the 35 MIT Innovators Under 35, and appeared in the Top 100 Global Thinkers by Foreign Policy Magazine.


June 28, 2017: Depolluted: Improving Indoor Air Quality in Uganda

Read more for details.


Peggy Lai, MD, is an assistant professor of medicine at Harvard Medical School, and a physician in the Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital. She is trained as a pulmonary physician and an environmental epidemiologist using 'omics to better understand the relationship between indoor air pollution and chronic lung diseases such as asthma and chronic obstructive pulmonary disease (COPD). She previously worked as a clinician in countries such as Guatemala, Liberia, Sierra Leone, Madagascar, and Uganda providing care to patients in resource limited settings. Lai currently conducts research on indoor air pollution and lung health in Boston, Massachusetts; Shanghai, China; and Mbarara, Uganda.


June 14, 2017: Decoded: DNA Repair and the Future of Cancer Treatment

Read more for details.


Zachary D. Nagel, PhD, is an assistant professor of radiation biology in the department of environmental health at the Harvard T.H. Chan School of Public Health. He received his BS in chemistry and German from the University of Michigan, obtained a PhD in chemistry from UC Berkeley, and carried out his postdoctoral research in the Department of Biological Engineering at MIT. Nagel's current research is focused on how DNA repair affects cancer therapy outcomes and disease risk. His work involves measuring the ability of human cells to repair their DNA, and using this information to predict how the cells will respond to DNA damaging agents, which are present in our environment, and are used to treat cancer. The long-term goal of this research is to develop new strategies for personalized cancer prevention and treatment.


May 24, 2017: Positive Effects: A Career in Public Health

Read more for details.


Sara Bleich, PhD, is a professor of public health policy at the Harvard T.H. Chan School of Public Health in the Department of Health Policy and Management. She is also the Carol K. Pforzheimer Professor at the Radcliffe Institute for Advanced Study. Bleich's scholarship lies at the nexus of health policy and health services research. Her research provides evidence to support policy alternatives for obesity prevention and control, particularly among populations at higher risk for obesity. A signature theme throughout her work is an interest in asking simple, meaningful questions about the complex problem of obesity which can fill important gaps in the literature. Her research has been published in journals such as the New England Journal of Medicine, Health Affairs, and American Journal of Public Health, and has been featured in outlets such as the New York Times, the Wall Street Journal, and National Public Radio. Bleich is the past recipient of an award for "most outstanding abstract" at the International Conference on Obesity in Sydney, Australia, an award for "best research manuscript" in the journal Obesity, and an award for excellence in public interest communication from the Frank Conference. She was appointed as a White House Fellow (2015-2016) where she was a senior policy advisor to the U.S. Department of Agriculture and the First Lady's Let's Move initiative. She holds a BA in psychology from Columbia University and a PhD in health policy from Harvard University.


May 10, 2017: Beyond Borders: Combating HIV in Africa

Read more for details.


Ingrid Katz, MD, is an assistant professor in medicine at Harvard Medical School. She serves as an associate physician in the Division of Women's Health and the Division of Medical Communications, in the Department of Medicine at Brigham and Women's Hospital, and is a research scientist at the Center for Global Health at Massachusetts General Hospital. She obtained a BA from Amherst College, and a MA in Health Science from Johns Hopkins Bloomberg School of Public Health before pursuing her degree in Medicine at University of California at San Francisco (AOA). After completing her medical training in internal medicine and infectious diseases, she received a Global Women's Health Fellowship to study HPV vaccine uptake among adolescents in Soweto, South Africa. Her current research focuses on factors affecting refusal to participate in HIV treatment programs among HIV-infected, treatment eligible adults presenting for testing.

Additional Resources


April 19, 2017: Health Decision Science: Assessing the Value of Information

Read more for details.


Ankur Pandya, PhD, is an assistant professor of health decision science in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health. His areas of interest are: applied decision science studies evaluating cardiovascular disease policies; connecting cost-effectiveness analysis with broader value-based health policies being implemented or piloted in U.S. health reform; and methodological topics within disease simulation modeling. Pandya's research has been covered in The New York Times, National Public Radio, NBC Nightly News, and other media outlets. He holds a BS from Cornell University in Nutritional Sciences, an MPH from Yale University in Health Policy and Administration, and graduated from the Harvard PhD Program in Health Policy.

Additional Resources


April 5, 2017: For Human Use: Bringing Together a Community to Fight Angiosarcoma

Read more for details.


Corrie Painter, PhD, is the associate director of operations and scientific outreach at the Broad Institute. A trained cancer researcher with a PhD in biochemistry, Painter partners with advocacy groups and engages patients with metastatic breast cancer through social media in order to carry out the Metastatic Breast Cancer Project, a genomics study conducted at the Broad Institute where patients can consent online to donate their stored tumor samples, saliva, medical records, and their voice in order to directly accelerate the pace of discovery.

Additional Resources


March 22, 2017: Other Side Effects: the economics of healthcare

Read more for details.


Anupam B. Jena, MD, PhD, is the Ruth L. Newhouse Associate Professor of Health Care Policy at Harvard Medical School and a physician in the Department of Medicine at Massachusetts General Hospital. He is also a faculty research fellow at the National Bureau of Economic Research. As an economist and a physician, Jena's research involves several areas of health economics and policy including the economics of physician behavior and the physician workforce, healthcare productivity, medical malpractice, and the economics of medical innovation. His work has been published in leading journals of medicine and economics and been featured in the New York Times, Washington Post, and other prominent news outlets. His work has been featured in several Freakonomics podcasts. Jena graduated Phi Beta Kappa from the Massachusetts Institute of Technology with majors in biology and economics. He received his MD and PhD in Economics from the University of Chicago, where he was funded by the NIH Medical Scientist Training Program. Jena completed his residency in internal medicine at Massachusetts General Hospital. In 2007, he was awarded the Eugene Garfield Award by Research America for his work demonstrating the economic value of medical innovation in HIV/AIDS. In 2013, Jena received the NIH Director's Early Independence Award to fund research on the physician determinants of healthcare spending, quality, and patient outcomes. In 2015, he was awarded the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) New Investigator Award. From 2014-15, Jena served as a member of the Institute of Medicine Committee on Diagnostic Errors in Healthcare.

Additional Resources


March 8, 2017: Let's Get Clinical: The role of physical activity in preventing disease

Read more for details.


I-Min Lee, MD, ScD, FACSM, is a professor of medicine at Harvard Medical School and professor of epidemiology at the Harvard T.H. Chan School of Public Health. Her primary area of interest is in the role of physical activity for preventing chronic diseases and enhancing longevity. Lee has served on national and international expert panels developing physical activity guidelines, including the 2008 US Physical Activity Guidelines, the 2010 WHO Global Recommendations on Physical Activity for Health, and the 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk.


February 22, 2017: Teach Them Young: Addressing the Childhood Obesity Epidemic Through After-School Programs

Read more for details.


Rebekka Lee, ScD, is a research scientist at the Harvard T.H. Chan School of Public Health. She has spent the past decade working at the Prevention Research Center on Nutrition and Physical Activity, where she currently uses mixed methods to conduct evaluation research with partners at the Boston Public Health Commission, Massachusetts Department of Public Health, and YMCA. Her research focuses on designing and evaluating community-based interventions that translate into real world policy and environmental change, focusing in particular on investigating the contextual factors that impact effective implementation and promote health equity. Lee completed her masters and doctoral degrees in the Department of Social and Behavior Sciences at the Harvard School of Public Health. She also serves as an Evaluation Consultant and instructor for the Population Health Research Program at Harvard Catalyst | The Harvard Clinical and Translational Science Center, providing training and technical assistance on mixed methods, implementation science, and community-based participatory research. Part of her work at Harvard Catalyst is leading a mixed methods implementation evaluation of nine clinical and community partnerships participating in the Prevention and Wellness Trust Fund. She was selected for the inaugural cohort of the Mentored Training for Dissemination and Implementation Research in Cancer and honed her knowledge of mixed methods in a master course with John W. Creswell, PhD.

Additional Resources


February 8, 2017: Clinical Thinking: Why Clinical Trials Matter

Read more for details.


Julie Buring, ScD, is a professor of medicine at Harvard Medical School and Brigham and Women's Hospital, and a professor of epidemiology at the Harvard T. H. Chan School of Public Health. The primary focus of her research is on the prevention of chronic diseases, especially among women. Buring has been involved in the design, conduct, analysis, and interpretation of a number of large-scale randomized clinical trials of the primary prevention of cardiovascular disease, cancer, and other chronic diseases. These include the Women's Health Study, evaluating the preventive roles of aspirin and vitamin E; the Physicians' Health Study II, evaluating vitamin E, vitamin C, beta-carotene, and a multivitamin; and VITAL, an ongoing trial of vitamin D and fish oil. She is actively involved in the teaching and training of students and fellows in epidemiology, both nationally and internationally, and is co-director of an NIH T32 training grant in the Epidemiology of Cardiovascular Disease. Buring serves as chair of the Institutional Review Board of Harvard Medical School.

Additional Resources


January 25, 2017: The VITAL study - Impact of Vitamins on chronic disease

Read more for details.


JoAnn Manson, MD, MPH, DrPH is professor of medicine and the Michael and Lee Bell Professor of Women's Health at Harvard Medical School. She is also chief of the Division of Preventive Medicine and co-director of the Connors Center for Women's Health and Gender Biology at Brigham and Women's Hospital. Manson is an endocrinologist, epidemiologist, and principal investigator of several research studies, including the VITamin D and OmegA-3 TriaL (VITAL); the Women's Health Initiative Clinical Center in Boston; the cardiovascular component of the Nurses' Health Study; the COcoa Supplement and Multivitamin Outcomes Study (COSMOS); and the Boston site of the Kronos Early Estrogen Prevention Study. She has received numerous honors, including the Woman in Science Award from the American Medical Women's Association, the American Heart Association's (AHA) Population Research Prize, the AHA's Distinguished Scientist Award, election to the Institute of Medicine of the National Academies (National Academy of Medicine), membership in the Association of American Physicians (AAP), and the 2013 Bernadine Healy Award for Visionary Leadership in Women's Health.

Additional Resources


January 11, 2017: Kidney Stones: The evolution of treatment with Dr. Peter Steinberg

Read more for details.


Peter Steinberg, MD, is Assistant Professor of Surgery at Harvard Medical School and Director of Endourology and Stone Management at BIDMC. He earned his medical degree from the University of Pennsylvania School of Medicine in Philadelphia. Steinberg completed a residency in urology at Dartmouth-Hitchcock Medical Center in New Hampshire and a fellowship in robotics, laparoscopy, and endourology at Montefiore Medical Center in New York. Board certified in urology, Steinberg's clinical interests include laparoscopy, robotics, and endourology, kidney stones, and general urology.

Additional Resources



December 7, 2016: Bio-inspiration: From nature to medical breakthrough with Dr. Jeff Karp

Read more for details.


Jeff Karp, PhD, is a world leader in drug delivery, stem cell therapeutics, and tissue adhesives. He is an Associate Professor at Brigham and Women's Hospital, Harvard Medical School, Principal Faculty at the Harvard Stem Cell Institute, and an affiliate faculty at the Broad Institute and at the Harvard-MIT Division of Health Sciences and Technology.



Additional Resources


Zika Virus: Understanding the Global Crisis with Dr. Laura Riley

Read more for details.


Bio: Laura Riley, MD, a Boston native, received her undergraduate education at Harvard University; her medical degree at the University of Pittsburgh and her residency in obstetrics and gynecology at the University of Pittsburgh-Magee Women's Hospital. She completed subspecialty training in maternal-fetal medicine at Brigham and Women's Hospital and in infectious disease at Boston University Medical Center. She is an Associate Professor of Obstetrics, Gynecology and Reproductive biology at Harvard Medical School. Riley joined the obstetrical service at Massachusetts General Hospital in 1995, where she focuses on high-risk pregnancy with an emphasis on infectious disease complications of obstetrics and she is the Vice Chair for Obstetrics. Nationally, serves as a consultant to the Centers for Disease Control on H1N1, Ebola virus, and Zika virus guidelines; she is the first ob/gyn member of the Advisory Committee on Immunization Practice.

Additional Resources


Reaching Clinical Mass: A Career in Community Based Research with Dr. Charles Deutsch

Read more for details.


Bio: Charles Deutsch, ScD is Director of the Harvard Catalyst Population Health Research Program (PHRP). Deutsch is responsible for the day-to-day leadership and operations of PHRP, which is the focal point for Harvard Catalyst's community engagement and population health research translation activities. Throughout his career he has worked to demonstrate coordinated and results-oriented engagement of academic health centers in applying what we know to what we do in health programs and policies.

Additional Resources


Diabetes: Advancing Research, Improving Treatment with Dr. Enrico Cagliero

Read more for details.


Bio: Enrico Cagliero, MD, completed his internship and residency at the University of California, San Diego, and his fellowship in Endocrinology at Massachusetts General Hospital. He then became an independent investigator at Harvard Medical School in 1990 and worked on the cellular mechanisms responsible for the vascular complications of diabetes. Cagliero joined the Diabetes Center at Massachusetts General Hospital in 1995, where he is now dividing his time between a busy clinical practice and his clinical research efforts. His major research interests include islet cell transplant for the treatment of type 1 diabetic patients and the development of new interventions for the prevention and treatment of type 1 and type 2 diabetes.

Additional Resources


Cows to Coumadin with Dr. Elliott Antman

Read more for details.


Bio: Elliott Antman, MD, is professor of medicine and an associate dean for Clinical/Translational Research at Harvard Medical School, a senior investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group, and a senior physician in the Cardiovascular Division of Brigham and Women's Hospital in Boston, Massachusetts. He was president of the American Heart Association (2014-2015) and is now the immediate past president. The American Heart Association honored him with the 2016 Paul Dudley White Award.

Additional Resources

Have ideas about what you would like to hear on the podcast? Email us!